Mitochondria: a promising target for anticancer alkaloids

Area of Science:

• Biochemistry
• Pharmacology
• Oncology

Background:

• Alkaloids are a significant class of compounds with demonstrated anticancer potential.
• Mitochondria play a crucial role in tumor progression, including resistance to cell death and proliferation.
• Targeting mitochondrial functions presents a promising strategy for cancer therapy.

Purpose of the Study:

• To review the multifaceted roles of alkaloids in targeting tumor mitochondria.
• To highlight mitochondria as a key organelle in the anticancer mechanisms of alkaloids.
• To underscore the importance of mitochondria in medicinal chemistry for cancer drug development.

Main Methods:

• Literature review of studies investigating alkaloid interactions with tumor mitochondria.
• Analysis of alkaloids' effects on mitochondrial functions such as OXPHOS, ROS production, and apoptosis.
• Examination of alkaloids' impact on mitochondrial morphology, biogenesis, and metabolic pathways.

Main Results:

• Alkaloids modulate mitochondrial oxidative phosphorylation (OXPHOS) and ADP/ATP transport.
• Many alkaloids increase reactive oxygen species (ROS) levels and dissipate mitochondrial potential.
• Alkaloids induce mitochondria-dependent apoptosis and autophagy, and inhibit mitochondrial metabolic pathways.

Conclusions:

• Mitochondria are central targets for the anticancer activities of various alkaloids.
• Alkaloid-induced mitochondrial dysfunction offers a promising strategy for novel anticancer drug design.
• Further research into organelle-specific delivery strategies for alkaloid derivatives is warranted.